Institute of Molecular and Cell Biology (Singapore)

Institute of Molecular and Cell Biology (Singapore)
Name	Institute of Molecular and Cell Biology
Established	1987
Type	A*STAR Research Institute
Director	Hong Wanjin
City	Singapore
Country	Singapore

Institute of Molecular and Cell Biology (Singapore). The Institute of Molecular and Cell Biology is a premier biomedical research institute under Singapore's Agency for Science, Technology and Research (A*STAR). Established in the late 1980s, it has been a cornerstone in building the nation's biomedical sciences sector, focusing on fundamental biological mechanisms and their implications for human health and disease. Its work spans areas such as cell biology, infectious diseases, and cancer biology, contributing significantly to Singapore's reputation as a global research hub.

History

The institute was conceived in 1985 by a panel led by Nobel laureate Sydney Brenner and formally established in 1987, initially operating from laboratories at the National University of Singapore. Its creation was a strategic move by the Singapore Government to develop a world-class research capability in the molecular life sciences. In 2004, it became a key component of the newly formed Biopolis, a purpose-built biomedical research complex in one-north, symbolizing its central role in Singapore's Biomedical Sciences Initiative. Early leadership under directors like Louis Lim and David Lane was instrumental in setting its scientific direction and recruiting top international talent, laying the foundation for its subsequent growth and impact.

Research

Research at the institute is organized into interdisciplinary themes centered on understanding fundamental biological processes. Major programs investigate signal transduction, membrane biology, genome regulation, and stem cell biology. Scientists employ advanced technologies in structural biology, proteomics, and genomics to study mechanisms underlying diseases such as cancer, metabolic disorders, and neurodegenerative diseases. A significant focus is also placed on host-pathogen interactions, particularly concerning dengue virus, Zika virus, and other regionally relevant infectious diseases. This translational approach aims to bridge basic discoveries to potential therapeutic and diagnostic applications.

Organisation and facilities

The institute is structured into research divisions and technology platforms, operating within the state-of-the-art Biopolis facilities. It houses core technology units for cryo-electron microscopy, next-generation sequencing, bioimaging, and biomolecular production. The A*STAR oversight ensures integration with other national research entities like the Singapore Immunology Network and the Genome Institute of Singapore. Leadership is provided by a director, historically including notable scientists like Sir David Lane and currently Hong Wanjin, supported by a management team and an international scientific advisory board comprising leaders from institutions like MRC Laboratory of Molecular Biology and Max Planck Society.

Key discoveries and achievements

Researchers have made landmark contributions, including pioneering work on the p53 tumor suppressor protein and its role in cancer. The institute's teams were among the first to identify key components of the Wnt signaling pathway and elucidate mechanisms of cell death (apoptosis). Significant advances have been made in understanding RNA interference and virology, particularly for the dengue virus, leading to novel antiviral strategies. Its scientists have received numerous accolades, including the President's Science and Technology Awards, and have published extensively in top-tier journals such as Nature, Cell, and Science.

Collaborations and partnerships

The institute maintains extensive collaborations with academic, clinical, and industrial partners globally. It works closely with local hospitals like Singapore General Hospital and universities including the National University of Singapore and Nanyang Technological University. International partnerships involve institutions such as the University of Cambridge, Karolinska Institutet, and the Riken institute. Strategic alliances with major pharmaceutical companies like GlaxoSmithKline and Roche facilitate drug discovery programs. It also plays a key role in regional initiatives, partnering with entities in ASEAN countries to build research capacity and address public health challenges.

Education and training

As a vital training ground, the institute hosts a robust PhD program in partnership with local universities under the A*STAR Graduate Academy. It offers postdoctoral fellowships and attracts international researchers through schemes like the A*STAR International Fellowship. The institute's scientists hold adjunct faculty positions at major universities and actively mentor young researchers. Outreach programs, including internships for undergraduates and attachments for students from schools like Raffles Institution, aim to inspire the next generation of scientists in Singapore and the wider region.

Category:Research institutes in Singapore Category:Biotechnology organisations based in Singapore Category:1987 establishments in Singapore